| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to compounds of formula,wherein pyridine rings A, B and C are independently unsubstituted or substituted by one or more substitutes independently specified in a group consisting of: C-alkyl, halogen alkyl having 1-6 carbon atoms, Hal or OR; Land Lare independently specified in residues having formulaor, wherein at least one of Lor Lhas formula (b); Rand Rare independently specified in a group consisting of hydrogen, C-alkyl and phenyl; Ris specified in hydrogen and C-alkyl; R, R, Rand Rare independently specified in a group consisting of hydrogen and C-alkyl; R, R, Rand Rare independently specified in a group consisting of hydrogen and C-alkyl; Ris specified in a group consisting of hydrogen and C-alkyl; Ris independently specified in a group consisting of hydrogen, C-alkyl and phenyl; p is equal to 1 or 2; q is equal to 0, 1 or 2, and Hal is specified in a group consisting of F, Cl, Br, and I, which can be used in treating a group of amyloid protein related disturbances and disorders.EFFECT: preparing the compounds which can be used in treating a group of amyloid protein related disturbances and disorders.17 cl, 1 dwg, 6 tbl, 13 ex |
